{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:15:41Z","timestamp":1790014541832,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773000"],"award-info":[{"award-number":["81773000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.gendis.2025.101915","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:52:43Z","timestamp":1761947563000},"page":"101915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["psiTPTE22-HERV functions as a tumor suppressor by inhibiting PI3K\/AKT\/mTOR\/EIF4E signaling"],"prefix":"10.1016","volume":"13","author":[{"given":"Fei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8496-3442","authenticated-orcid":false,"given":"Jessie Qiaoyi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gendis.2025.101915_bib1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.gendis.2025.101915_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/labinvest.3780422","article-title":"Promoter methylation and silencing of PTEN in gastric carcinoma","volume":"82","author":"Kang","year":"2002","journal-title":"Lab Invest"},{"issue":"3","key":"10.1016\/j.gendis.2025.101915_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/onc.2012.54","article-title":"Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer","volume":"32","author":"Yu","year":"2013","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.gendis.2025.101915_bib4","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/gutjnl-2015-309276","article-title":"MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome","volume":"65","author":"Wang","year":"2016","journal-title":"Gut"},{"issue":"19","key":"10.1016\/j.gendis.2025.101915_bib5","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1038\/onc.2015.300","article-title":"Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK\/c-Jun\/AP-1 pathway","volume":"35","author":"Li","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.gendis.2025.101915_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/onc.2016.187","article-title":"REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.gendis.2025.101915_bib7","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1073\/pnas.93.11.5177","article-title":"The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences","volume":"93","author":"L\u00f6wer","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.gendis.2025.101915_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/geno.1999.5877","article-title":"Endogenous retroviruses provide the primary polyadenylation signal for two new human genes (HHLA2 and HHLA3)","volume":"59","author":"Mager","year":"1999","journal-title":"Genomics"},{"issue":"25","key":"10.1016\/j.gendis.2025.101915_bib9","doi-asserted-by":"crossref","first-page":"14759","DOI":"10.1073\/pnas.93.25.14759","article-title":"Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus","volume":"93","author":"Schulte","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.gendis.2025.101915_bib10","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/ijc.25213","article-title":"The novel human endogenous retrovirus-related gene, psiTPTE22-HERV is silenced by DNA methylation in cancers","volume":"127","author":"Liang","year":"2010","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101915_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12864-018-4775-x","article-title":"TSVdb: a web-tool for TCGA splicing variants analysis","volume":"19","author":"Sun","year":"2018","journal-title":"BMC Genomics"},{"issue":"7517","key":"10.1016\/j.gendis.2025.101915_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.gendis.2025.101915_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"8","key":"10.1016\/j.gendis.2025.101915_bib14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/j.gendis.2025.101915_bib15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"W1","key":"10.1016\/j.gendis.2025.101915_bib16","doi-asserted-by":"crossref","first-page":"W415","DOI":"10.1093\/nar\/gkae456","article-title":"WebGestalt 2024: faster gene set analysis and new support for metabolomics and multi-omics","volume":"52","author":"Elizarraras","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.gendis.2025.101915_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gendis.2025.101915_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12885-019-5667-4","article-title":"Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer","volume":"19","author":"Rutkovsky","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.gendis.2025.101915_bib19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1101\/gad.12.4.502","article-title":"4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt (PKB) signaling pathway","volume":"12","author":"Gingras","year":"1998","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.gendis.2025.101915_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.62347\/MTSD6746","article-title":"High EIF4EBP1 expression reflects mTOR pathway activity and cancer cell proliferation and is a biomarker for poor breast cancer prognosis","volume":"14","author":"Nelson","year":"2024","journal-title":"Am J Cancer Res"},{"issue":"6980","key":"10.1016\/j.gendis.2025.101915_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","article-title":"Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Wendel","year":"2004","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.gendis.2025.101915_bib22","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.2174\/0929867329666220224112042","article-title":"The mTOR\/4E-BP1\/eIF4E signalling pathway as a source of cancer drug targets","volume":"29","author":"Maracci","year":"2022","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.gendis.2025.101915_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/imr.12240","article-title":"The eukaryotic translation initiation factor eIF4E in the nucleus: taking the road less traveled","volume":"263","author":"Osborne","year":"2015","journal-title":"Immunol Rev"},{"issue":"18","key":"10.1016\/j.gendis.2025.101915_bib24","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1038\/sj.onc.1207550","article-title":"An essential role for protein synthesis in oncogenic cellular transformation","volume":"23","author":"Bader","year":"2004","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.gendis.2025.101915_bib25","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3390\/cancers6031441","article-title":"The role of PI3K\/Akt\/mTOR signaling in gastric carcinoma","volume":"6","author":"Matsuoka","year":"2014","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.gendis.2025.101915_bib26","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3892\/or.2013.2397","article-title":"Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth","volume":"29","author":"Liang","year":"2013","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.gendis.2025.101915_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jso.20037","article-title":"Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome","volume":"86","author":"Chen","year":"2004","journal-title":"J Surg Oncol"},{"issue":"21","key":"10.1016\/j.gendis.2025.101915_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111376","article-title":"Proteotoxic stress as an exploitable vulnerability in cells with hyperactive AKT","volume":"22","author":"Babagana","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.gendis.2025.101915_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039679","article-title":"mTOR is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesis","volume":"7","author":"Chou","year":"2012","journal-title":"PLoS One"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:43:50Z","timestamp":1790012630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225004040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2352304225004040"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101915","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"psiTPTE22-HERV functions as a tumor suppressor by inhibiting PI3K\/AKT\/mTOR\/EIF4E signaling","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101915"}}